R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT00504491 · WITHDRAWN

Trial details

NCT number: NCT00504491
Sponsor: CABYC
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukaemia Patients Resistant to a Purine Analogous Patients Relapsed With Purines Therapy

Start date: 2007-07-01
Primary completion: 2012-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.